Despite a tumultuous year of changes and proposed changes to the way the federal government invests in scientific research, the director of the National Cancer Institute, Anthony Letai, MD, PhD, sees ...

Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more ...